Biosenta Inc. (ZRO.CN)
| Previous Close | 0.3350 |
| Open | 0.0000 |
| Bid | 0.3300 x N/A |
| Ask | 0.4950 x N/A |
| Day's Range | 0.3350 - 0.3350 |
| 52 Week Range | 0.1500 - 0.8900 |
| Volume | |
| Avg. Volume | 1,490 |
| Market Cap | 9.922M |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2500 |
| Earnings Date | May 27, 2024 - May 31, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Biosenta Closes Private Placement Financing
Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - Biosenta Inc. (CSE: ZRO) (the "Company" or "Biosenta"), is pleased to announce that it has closed its private placement for gross proceeds of $600,000 (the "Offering"), as previously announced on April 19, 2024. Biosenta issued 1,500,000 units (each, a "Unit") under the Offering at a price of $0.40 per Unit, with each Unit consisting of one common share in the capital of the Company (each, a ...
- Newsfile
Biosenta Announces Private Placement Financing
Toronto, Ontario--(Newsfile Corp. - April 19, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a non-brokered private placement financing (the "Offering") of up 1,500,000 units of the Company (the "Units") at a price of $0.40 per Unit, for aggregate gross proceeds of up to $600,000.Each Unit will consist of one common share in the capital of the Company and one half of one common share purchase warrant (each ...
- Newsfile
Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology
Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - March 27, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a significant milestone in its technological and operational advancements with the successful construction and operation of a bench scale production plant. The results from this production not only surpassed our expectations, but also showcased that our patented Tri-Filler™ antimicrobial technology is ready for accelerated development and scalin
